Home › Funds › Edgemoor Investment Advisors, Inc. › VRTX

Edgemoor Investment Advisors, Inc. position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Edgemoor Investment Advisors, Inc. reported holding 54,831 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$28.7M, representing 2.01% of its reported portfolio and ranking #14 among its reported holdings. Edgemoor Investment Advisors, Inc. has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)54.83K sh
Reported value held$28.67M
Portfolio Weight2.01%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Edgemoor Investment Advisors, Inc.'s VRTX position evolved

Edgemoor Investment Advisors, Inc. first disclosed a stake in VRTX in Q3 2023 at 55,838 shares (US$19.4M). The position peaked in Q3 2026 at 54,831 shares, worth US$28.7M. Across 13 filings, Edgemoor Investment Advisors, Inc. increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 54,831 shares valued at US$28.7M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 55.84K $19.42M New
Q4 2023 56.38K $22.94M Add
Q1 2024 56.53K $23.63M Hold
Q2 2024 56.88K $26.66M Add
Q3 2024 57.01K $26.51M Hold
Q4 2024 57.10K $22.99M Hold
Q1 2025 56.80K $27.54M Reduce
Q2 2025 56.02K $24.94M Reduce
Q3 2025 55.19K $21.62M Reduce
Q4 2025 54.84K $24.86M Reduce
Q1 2026 55.41K $24.75M Add
Q2 2026 55.02K $27.33M Reduce
Q3 2026 54.83K $28.67M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Edgemoor Investment Advisors, Inc. held VRTX?

Edgemoor Investment Advisors, Inc. has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Edgemoor Investment Advisors, Inc.'s current position in VRTX?

As of Q3 2026, Edgemoor Investment Advisors, Inc. holds 54.83K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $28.67M, representing 2.01% of its reported portfolio and ranking #14.

Has Edgemoor Investment Advisors, Inc. been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Edgemoor Investment Advisors, Inc. held unchanged its position in VRTX. The position peaked in Q3 2026 at 54.83K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.